TELETRADER News
9/8/2020, 11:58 PM (Source: TeleTrader)
more TeleTrader news

AstraZeneca vaccine study on hold due to possible adverse reaction

AstraZeneca's coronavirus vaccine study was placed on hold due to a suspected serious adverse reaction in one participant in the United Kingdom, Stat reported.

A spokesperson for AstraZeneca said that the company’s "standard review process triggered a pause to vaccination to allow review of safety data," while adding that the pharmaceutical giant is "working to expedite the review of the single event to minimize any potential impact on the trial timeline."

The exact nature of the possible adverse reaction to AstraZeneca's coronavirus vaccine candidate is currently unknown as no other details have been made public.

Breaking the News / JC